A real-world observational study of treatment patterns and outcomes for patients with neuromyelitis optica spectrum disorders (NMOSD) treated with inebilizumab (UPLIZNA) in Europe

ENCePP Code of conduct

Yes

Data sources

• Data source(s):
  Système National des Données de Santé (French national health system main database)

  PHARMO Data Network

  The Information System for Research in Primary Care (SIDIAP)
• Data source(s), other:
  Observatoire Français de la Sclérose en Plaques (OFSEP); Gesetzliche Krankenversicherung (GKV); Registro Italiano Sclerosi Multipla e Patologie Correlate (RISM)

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown